Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5A.
Horton, J.R., Liu, X., Wu, L., Zhang, K., Shanks, J., Zhang, X., Rai, G., Mott, B.T., Jansen, D.J., Kales, S.C., Henderson, M.J., Pohida, K., Fang, Y., Hu, X., Jadhav, A., Maloney, D.J., Hall, M.D., Simeonov, A., Fu, H., Vertino, P.M., Yan, Q., Cheng, X.(2018) J Med Chem 61: 3193-3208
- PubMed: 29537847 
- DOI: https://doi.org/10.1021/acs.jmedchem.8b00261
- Primary Citation of Related Structures:  
6BGU, 6BGV, 6BGW, 6BGX, 6BGY, 6BGZ, 6BH0, 6BH1, 6BH2, 6BH3, 6BH4, 6BH5 - PubMed Abstract: 
Isomers of chiral drugs can exhibit marked differences in biological activities. We studied the binding and inhibitory activities of 12 compounds against KDM5A. Among them are two pairs of enantiomers representing two distinct inhibitor chemotypes, namely, ( R)- and ( S)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1 H-pyrrolo[3,2- b]pyridine-7-carboxylic acid (compounds N51 and N52) and ( R) - and ( S) -N-(1-(3-isopropyl-1 H-pyrazole-5-carbonyl)pyrrolidin-3-yl)cyclopropanecarboxamide (compounds N54 and N55) ...